Optaflexx 100 Premix (Canada)This page contains information on Optaflexx 100 Premix for veterinary use.
The information provided typically includes the following:
- Optaflexx 100 Premix Indications
- Warnings and cautions for Optaflexx 100 Premix
- Direction and dosage information for Optaflexx 100 Premix
Optaflexx 100 PremixThis treatment applies to the following species:
ACTIVE DRUG INGREDIENT:
100 g per kg
FOR USE IN CONFINED CATTLE FEEDS ONLY.
For increased rate of weight gain, improved feed efficiency and increased carcass leanness in confined cattle greater than 400 kg, when fed during the last 28 to 42 days prior to slaughter.
Recommended dosage of ractopamine hydrochloride:
- 10-30 ppm in final feed for increased rate of weight gain and improved feed efficiency
- 20-30 ppm in final feed for improved carcass leanness
Must be thoroughly mixed into feeds before use.
Do not feed undiluted.
Thoroughly mix 100 to 300 grams of Optaflexx 100 Premix in 1000 kg of complete beef feed (100% dry matter basis) to provide from 10 to 30 ppm ractopamine hydrochloride per tonne of feed. To insure adequate mixing, an intermediate blending step should be performed prior to manufacturing a complete feed.
Optaflexx 100 Premix can be used in liquid feed supplements for further blending into complete beef feed. Optaflexx medicated liquid feed supplements must be maintained at pH 4.5-7.5 and not used after nine weeks storage.
Feed continuously as the sole ration to finishing cattle greater than 400 kg for 28 to 42 days prior to slaughter.
No withdrawal period is required in cattle when treated according to the label.
Do not use in calves to be processed for veal.
When mixing and handling Optaflexx 100 Premix, use protective clothing, impervious gloves, and a dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse eyes thoroughly with water.
The active ingredient in OPTAFLEXX 100 is ractopamine hydrochloride. Ractopamine hydrochloride is a beta-adrenergic agonist. Individuals with cardiovascular disease should exercise special caution to avoid exposure.
Keep out of reach of children.
Not for use in humans.
Storage: Store at or below 25° C.
*Elanco®, Optaflexx®, and the diagonal bar are trademarks of Eli Lilly and Company.
ELANCO® Division Eli Lilly Canada Inc., 150 Research Lane, Suite 120, Guelph, Ontario, Canada N1G 4T2
NAC No.: 11840272
Division Eli Lilly Canada Inc.
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Every effort has been made to ensure the accuracy of the Optaflexx 100 Premix information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2014-12-03